Most cited papers from Eli Lilly (India)

Eli Lilly (India)

What are the most cited papers from Eli Lilly (India)?

The most cited paper from Eli Lilly (India) is "Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death" (Edward H Abraham, Pierre‐François Laterre, Rekha Garg et al., 2005), with 897 citations. Next come "The Role of Diet and Nutrition in Migraine Triggers and Treatment: A Systematic Literature Review" (208) and "HbA1c Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression" (149).

Published TypeFieldAccessCitations

Showing 50 of 60 papers. Every paper with more than 9 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death Edward H Abraham, Pierre‐François Laterre, Rekha Garg et al. · New England Journal of Medicine Open access	28 Sep 2005	897
2	The Role of Diet and Nutrition in Migraine Triggers and Treatment: A Systematic Literature Review Nada Ahmad Hindiyeh, Niushen Zhang, Mallory Farrar et al. · Headache The Journal of Head and Face Pain ReviewOpen access	25 May 2020	208
3	HbA1c Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression Mary Angelyn Bethel, Rafael Ugarriza Díaz, Noelia Castellana et al. · Diabetes Care ReviewOpen access	14 Dec 2020	149
4	A Phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer Dinesh Chandra Doval, Jagdev Singh Sekhon, Sunil Kumar Gupta et al. · British Journal of Cancer Open access	16 Mar 2004	137
5	Improved mealtime treatment of diabetes mellitus using an insulin analogue James H. Anderson · Clinical Therapeutics	Feb 1997	118
6	Weight reduction and the impact on apnea-hypopnea index: A systematic meta-analysis Atul Malhotra, Cory R. Heilmann, Kushal K. Banerjee et al. · Sleep Medicine Open access	15 Jun 2024	87
7	Receptor binding and biological potency of several split forms (conversion intermediates) of human proinsulin. Studies in cultured IM-9 lymphocytes and in vivo and in vitro in rats. Daniel E. Peavy, Melanie Brunner, William C. Duckworth et al. · Journal of Biological Chemistry Open access	Nov 1985	80
8	Global Consumption Trend of Antifungal Agents in Humans From 2008 to 2018: Data From 65 Middle- and High-Income Countries Swathi Pathadka, Vincent Ka Chun Yan, Chin Fen Neoh et al. · Drugs Open access	Jul 2022	75
9	Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes: Past, present, and future Omolara Adetunji, Sanjay Kalra, ManashP Baruah et al. · Indian Journal of Endocrinology and Metabolism Open access	2016	72
10	Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real‐world setting Elizabeth R. Seaquist, Hélène Dulude, Xiaotian Michelle Zhang et al. · Diabetes Obesity and Metabolism Open access	5 Mar 2018	54
11	Readability and comprehensibility of informed consent forms for clinical trials. Anvita Pandiya · PubMed Open access	Jul 2010	53
12	Applications of Quantum Chemistry in Pharmaceutical Process Development: Current State and Opportunities Yu‐hong Lam, Yuriy A. Abramov, Ravi S. Ananthula et al. · Organic Process Research & Development	23 Jul 2020	51
13	Meta-Analysis of Suicide-Related Behavior or Ideation in Child, Adolescent, and Adult Patients Treated with Atomoxetine Mark E. Bangs, Linda A. Wietecha, Shufang Wang et al. · Journal of Child and Adolescent Psychopharmacology ReviewOpen access	14 Jul 2014	51
14	Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial Richard M. Bergenstal, Ruth S. Weinstock, Chantal Mathieu et al. · The Lancet	Sep 2024	50
15	A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with type 1 diabetes in the home or school setti Larry C. Deeb, Hélène Dulude, Cristina B. Guzmán et al. · Pediatric Diabetes Open access	7 Mar 2018	50
16	Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation Clifton O. Bingham, Carol L. Gaich, Amy M. DeLozier et al. · Trials Open access	22 Mar 2019	49
17	Neuropsychiatric events associated with montelukast in patients with asthma: a systematic review Chris Wai Hang Lo, Swathi Pathadka, Simon Xiwen Qin et al. · European Respiratory Review ReviewOpen access	27 Sep 2023	45
18	A Randomized Phase 2 Study of Gefitinib With or Without Pemetrexed as First-line Treatment in Nonsquamous NSCLC With EGFR Mutation: Final Overall Survival and Biomarker Analysis James Chih‐Hsin Yang, Ying Cheng, Haruyasu Murakami et al. · Journal of Thoracic Oncology Open access	9 Oct 2019	45
19	A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using molecular profiling P. K. Julka, R. T. Chacko, Shinjini Nag et al. · British Journal of Cancer Open access	Apr 2008	44
20	Efficacy of galcanezumab in patients with chronic migraine and a history of preventive treatment failure Dustin D. Ruff, Janet H. Ford, Antje Tockhorn‐Heidenreich et al. · Cephalalgia	19 May 2019	42
21	Efficacy of galcanezumab in patients with episodic migraine and a history of preventive treatment failure: results from two global randomized clinical trials D. D. Ruff, James H. Ford, Antje Tockhorn‐Heidenreich et al. · European Journal of Neurology Open access	6 Nov 2019	40
22	Scaling Organic Electrosynthesis: The Crucial Interplay between Mechanism and Mass Transport Zachary J. Oliver et al. · ACS Central Science Open access	11 Feb 2025	38
23	Psychometric validation and meaningful within‐patient change of the Migraine‐Specific Quality of Life questionnaire version 2.1 electronic patient‐reported outcome in patients with episodic and chronic migraine Rebecca M. Speck, Ren Yu, Janet H. Ford et al. · Headache The Journal of Head and Face Pain Open access	22 Jan 2021	36
24	Clinical, Economic, and Patient-Reported Benefits of Connected Insulin Pen Systems: A Systematic Literature Review IAIN C. CRANSTON, Vinayak Jamdade, Birong Liao et al. · Advances in Therapy ReviewOpen access	16 Mar 2023	35
25	Adherence and Persistence to Insulin Therapy in People with Diabetes: Impact of Connected Insulin Pen Delivery Ecosystem Devin Steenkamp, Elizabeth L. Eby, Nany Gulati et al. · Journal of Diabetes Science and Technology Open access	5 Mar 2021	34
26	Inhibition of venom phospholipases A2 by manoalide and manoalogue. Stoichiometry of incorporation. Laure J. Reynolds, Edward D. Mihelich, Edward A. Dennis · Journal of Biological Chemistry Open access	Sep 1991	34
27	Mechanistic Study of Diketopiperazine Formation during Solid-Phase Peptide Synthesis of Tirzepatide Jingyao Wang, Mark R. Berglund, Timothy M. Braden et al. · ACS Omega Open access	6 Dec 2022	32
28	Efficacy and safety of tirzepatide in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial Tamara S. Hannon, Lily C. Chao, Margarita Barrientos‐Pérez et al. · The Lancet	17 Sep 2025	31
29	A Molecular Dynamics Study of Antimicrobial Peptide Interactions with the Lipopolysaccharides of the Outer Bacterial Membrane Pradyumn Sharma, K. G. Ayappa · The Journal of Membrane Biology	12 Aug 2022	29
30	First-Line Pemetrexed plus Cisplatin followed by Gefitinib Maintenance Therapy versus Gefitinib Monotherapy in East Asian Never-Smoker Patients with Locally Advanced or Metastatic Nonsquamous Non–Small Cell Lung Cancer: Final Overall Survival Results from a Randomized Phase 3 Study James Chih‐Hsin Yang, Vichien Srimuninnimit, Myung‐Ju Ahn et al. · Journal of Thoracic Oncology Open access	25 Dec 2015	28
31	A Review of Regimens Combining Pemetrexed With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in the Treatment of Advanced Nonsquamous Non–Small-Cell Lung Cancer James Chih‐Hsin Yang, Tony S.K. Mok, Baohui Han et al. · Clinical Lung Cancer Open access	5 Jul 2017	24
32	Estimation of acceptable daily intake values based on modeling and in vivo mutagenicity of NDSRIs of fluoxetine, duloxetine and atomoxetine Robert A. Jolly, Paul D. Cornwell, Jessica Noteboom et al. · Regulatory Toxicology and Pharmacology	4 Jul 2024	23
33	Patterns and trends in insulin initiation and intensification among patients with Type 2 diabetes mellitus in the Middle East and North Africa region Abdul Jabbar, Khalifa Abdallah, Ahmed Abdul Karim Hassoun et al. · Diabetes Research and Clinical Practice Open access	14 Jan 2019	22
34	Humalog ® Mix50™ before carbohydrate‐rich meals in type 2 diabetes mellitus Paris J. Roach, Vipin K Arora, Barbara N. Campaigne et al. · Diabetes Obesity and Metabolism	27 Aug 2003	22
35	ControlPolypNet: Towards Controlled Colon Polyp Synthesis for Improved Polyp Segmentation Vanshali Sharma, Abhishek Kumar, Debesh Jha et al. Conference paper	17 Jun 2024	21
36	East Asian Subgroup Analysis of a Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-small Cell Lung Cancer Following Disease Progression after One Prior Platinum-Based Therapy (REVEL) Keunchil Park, Joo-Hang Kim, Eun Kyung Cho et al. · Cancer Research and Treatment Open access	3 May 2016	21
37	RELAY: Final Overall Survival for Erlotinib Plus Ramucirumab or Placebo in Untreated, EGFR-Mutated Metastatic NSCLC Kazuhiko Nakagawa, Edward B. Garon, Takashi Seto et al. · Journal of Thoracic Oncology Open access	30 Nov 2024	20
38	Clinical Investigation of Large Volume Subcutaneous Delivery up to 25 mL for Lean and Non-Lean Subjects Xiangnan Dang, Han Shih, Rakesh Kumar Sharma et al. · Pharmaceutical Research	5 Mar 2024	20
39	Clinical outcomes of ramucirumab plus docetaxel in the treatment of patients with non-small cell lung cancer after immunotherapy: a systematic literature review Edward B. Garon, Carla Visseren‐Grul, Maria Teresa Rizzo et al. · Frontiers in Oncology ReviewOpen access	4 Sep 2023	19
40	Evaluation of Predictive Solubility Models in Pharmaceutical Process Development─an Enabling Technologies Consortium Collaboration Michael A. Lovette, Jacob W. Albrecht, Ravi S. Ananthula et al. · Crystal Growth & Design	22 Aug 2022	19
41	Quality of independent review board/ethics committee oversight in clinical trials in India Anvita Pandiya · Perspectives in Clinical Research Open access	2011	19
42	BIOBETTERS: THE BETTER BIOLOGICS AND THEIR REGULATORY OVERVIEW Sandeep Kumar Verma, Parveen Jain, P. Chauhan · International Journal of Drug Regulatory Affairs Open access	13 Feb 2018	18
43	Personalized medicine: An overview Vijay Kumar Mishra, Puja Chanda, Murtaza M. Tambuwala et al. · International Journal of Pharmaceutical Quality Assurance Open access	24 Jun 2019	16
44	The Trend of High-Dose Insulin Usage Among Patients with Diabetes in the UK: A Retrospective Study ISKANDAR RAUF IDRIS, Xiaomei Peng, Xuanyao He et al. · Diabetes Therapy Open access	29 Sep 2018	16
45	Rainfall variability over multiple cities of India: analysis and forecasting using deep learning models Jagabandhu Panda, Nistha Nagar, Asmita Mukherjee et al. · Earth Science Informatics	6 Feb 2024	15
46	Efficacy of Galcanezumab in Patients Who Failed to Respond to Preventives Previously: Results from EVOLVE-1, EVOLVE-2 and REGAIN Studies (S20.004) Qi Zhang, Dustin D. Ruff, Eric M. Pearlman et al. · Neurology	10 Apr 2018	15
47	First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients With Locally Advanced or Metastatic Nonsquamous Non–Small-cell Lung Cancer: Quality of Life Results From a Randomized Phase III Trial Mark E. Boye, Xin Wang, Vichien Srimuninnimit et al. · Clinical Lung Cancer Open access	18 Dec 2015	14
48	Economics of Inhaled Oxygen Use as an Acute Therapy for Cluster Headache in the United States of America Megan E. O’Brien, Janet H. Ford, Sheena K. Aurora et al. · Headache The Journal of Head and Face Pain	26 Aug 2017	13
49	Trends of HbA1c and BMI in People with Type 2 Diabetes: A Japanese Claims-Based Study Kazuo Hara, Tetsuaki Hirase, Swathi Pathadka et al. · Diabetes Therapy Open access	24 Feb 2024	12
50	The Development of an Exercise Advisor App for Type 1 Diabetes: Digitization Facilitates More Individualized Guidance SARAH M. MCGAUGH, Stephanie Edwards, Howard A. Wolpert et al. · Journal of Diabetes Science and Technology Open access	20 Dec 2020	12

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.